150 related articles for article (PubMed ID: 736631)
1. [Cell mediated immunity in cervical cancer patients: evaluation by in vitro leukocyte-migration-inhibition-assay (author's transl)].
Koenig UD
Arch Gynecol; 1978 Dec; 226(4):315-24. PubMed ID: 736631
[TBL] [Abstract][Full Text] [Related]
2. Cell mediated immune reactions to autologous and homologous tumor tissue in cervical cancer patients.
Koenig UD
Obstet Gynecol Surv; 1979 Nov; 34(11):857-9. PubMed ID: 523041
[No Abstract] [Full Text] [Related]
3. [The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
Schmeisser G; Kademann J
Arch Geschwulstforsch; 1980; 50(2):169-72. PubMed ID: 7436701
[TBL] [Abstract][Full Text] [Related]
4. [Studies on LMIT of cervical cancer (author's transl)].
Yamamoto H
Acta Obstet Gynaecol Jpn; 1980 Dec; 32(12):1917-26. PubMed ID: 7211210
[No Abstract] [Full Text] [Related]
5. [Diagnosis of cellular immune reactions against autologous and homologous tumor tissue in cervix cancer patients using the direct leukocyte migration inhibition test].
Koenig UD
Arch Gynecol; 1979 Jul; 228(1-4):597-8. PubMed ID: 485496
[No Abstract] [Full Text] [Related]
6. [Sensitization of lymphocyte to tumor extract detected by macrophage migration inhibition test(MIT) in patients with cervical cancer (author's transl)].
Ohno M
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):919-28. PubMed ID: 7240870
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
[No Abstract] [Full Text] [Related]
8. [Studies on the immune status of patients with operated and irradiated cervical and breast cancer. III. Comparative investigation of the immune status of patients with breast cancer treated by operation and irradiation and of patients with cervical cancer treated either by operation or irradiation (author's transl)].
Palencia C; Wicke L; Kärcher KH; Gitsch E; Hernuss P; Steffen C
Wien Klin Wochenschr; 1976 Aug; 88(15):495-501. PubMed ID: 997530
[TBL] [Abstract][Full Text] [Related]
9. [Cell-mediated immunity in myoma uteri measured by the leukocyte migration inhibition test (author's transl)].
Lunow E
Zentralbl Gynakol; 1979; 101(8):515-22. PubMed ID: 463417
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immunity in cervical cancer evolution.
Jandová A; Pokorný J; Kobilková J; Janousek M; Masata J; Trojan S; Nedbalová M; Dohnalová A; Beková A; Slavík V; Cocek A; Sanitrák J
Electromagn Biol Med; 2009; 28(1):1-14. PubMed ID: 19337890
[TBL] [Abstract][Full Text] [Related]
12. [Studies on host immunity in cervical cancer--alterations in nonspecific and specific immunity of tumor growth (author's transl)].
Yamada Y
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Nov; 32(11):1820-8. PubMed ID: 7240835
[TBL] [Abstract][Full Text] [Related]
13. Human cell-mediated immunity to tuberculin as assayed by the agarose micro-droplet leukocyte migration inhibition technique: comparison with the capillary tube assay.
McCoy JL; Dean JH; Herberman RB
J Immunol Methods; 1977; 15(4):355-71. PubMed ID: 874326
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immunity in patients with cervical cancer.
Cerni C; Tatra G; Berger R; Micksche M
Oncology; 1979; 36(4):164-70. PubMed ID: 224356
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of leucocyte migration by tumour-associated antigens of the colon and rectum.
Guillou PJ; Giles GR
Gut; 1973 Sep; 14(9):733-8. PubMed ID: 4201667
[TBL] [Abstract][Full Text] [Related]
16. [Irradiated cases of cervical and breast cancer II. Comparative investigation of the immune status of irradiated cases with stage III cancer of the cervix and operated, non-irradiated cases (author's transl)].
Palencia C; Hernuss P; Gitsch E; Weghaupt K; Wicke L; Kärcher KH; Steffen C
Wien Klin Wochenschr; 1975 Dec; 87(24):809-15. PubMed ID: 1084083
[TBL] [Abstract][Full Text] [Related]
17. [Cellular immunity in melanomalignome (author's transl)].
Fritz J; Grond K; Tilz GP
Arch Dermatol Res (1975); 1976 Apr; 255(2):203-9. PubMed ID: 1275554
[TBL] [Abstract][Full Text] [Related]
18. [Studies on immunospecificity of skin test using tumor extract in gynecological malignancy (author's transl)].
Yuzawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):611-8. PubMed ID: 6165790
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration.
Ablin RJ; Marrow C; Guinan PD; Bruns GR; Sadoughi N; John T; Bush IM
Urol Int; 1976; 31(6):444-58. PubMed ID: 1006873
[TBL] [Abstract][Full Text] [Related]
20. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
Abai AM; Fekete B
Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
